Invasive Mechanical Ventilation and Risk of Hospital-Acquired Venous Thromboembolism

REFERENCES

1. 1.↵
   Children’s Hospitals’ Solutions for Patient Safety. Our results: VTE Non-CVC Events Rate. https://www.solutionsforpatientsafety.org/our-results. Accessed September 6, 2023.
2. 2.↵
   1. Setty BA,
   2. O’Brien SH,
   3. Kerlin BA

   . Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases. Pediatr Blood Cancer 2012;59(2):258-264.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Sochet AA,
   2. Kiskaddon A,
   3. Betensky M,
   4. Goldenberg N

   . Venous thromboembolism among critically ill children: a narrative review. Semin Thromb Hemost 2021;47(6):631-642.

   OpenUrlPubMed
4. 4.↵
   1. Higgerson RA,
   2. Lawson KA,
   3. Christie LM,
   4. Brown AM,
   5. McArthur JA,
   6. Totapally BR,
   7. Hanson SJ

   ; National Association of Children’s Hospitals and Related Institution’s Pediatric Intensive Care Unit FOCUS group. Incidence and risk factors associated with venous thrombotic events in pediatric intensive care unit patients. Pediatr Crit Care Med 2011;12(6):628-634.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Tran M,
   2. Shein SL,
   3. Ji X,
   4. Ahuja SP

   . Identification of a “VTE-rich” population in pediatrics - critically ill children with central venous catheters. Thromb Res 2018;161:73-77.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Patel N,
   2. Petersen TL,
   3. Simpson PM,
   4. Feng M,
   5. Hanson SJ

   . Rates of venous thromboembolism and central line–associated blood stream infections among types of central venous access devices in critically ill children. Crit Care Med 2020;48(9):1340-1348.

   OpenUrlPubMed
7. 7.↵
   1. Gonzalez AB,
   2. Mulet YM,
   3. Song N,
   4. Loh L,
   5. Scheinker D,
   6. Shin AY,
   7. Donnelly LF

   . Predictive Ability of the Braden QD scale for hospital-acquired venous thromboembolism in hospitalized children. Jt Comm J Qual Patient Saf 2022;48(10):513-520.

   OpenUrlPubMed
8. 8.↵
   1. Jaffray J,
   2. Mahajerin A,
   3. Branchford B,
   4. Nguyen ATH,
   5. Faustino EVS,
   6. Silvey M,
   7. et al

   . A new risk assessment model for hospital-acquired venous thromboembolism in critically ill children: a report from the Children’s Hospital-Acquired Thrombosis Consortium. Pediatr Crit Care Med 2022;23(1):e1-e9.

   OpenUrl
9. 9.↵
   1. Robriquet L,
   2. Guery B,
   3. Fourrier F

   . Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia. Crit Care Med 2006;34(9):2510; author reply 2510-2511.

   OpenUrlPubMed
10. 10.↵
    1. Wygrecka M,
    2. Jablonska E,
    3. Guenther A,
    4. Preissner KT,
    5. Markart P

    . Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thromb Haemost 2008;99(3):494-501.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Glas GJ,
    2. Van Der Sluijs KF,
    3. Schultz MJ,
    4. Hofstra JJ,
    5. Van Der Poll T,
    6. Levi M

    . Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome. J Thromb Haemost 2013;11(1):17-25.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Branchford BR,
    2. Carpenter SL

    . The role of inflammation in venous thromboembolism. Front Pediatr 2018;6:142.

    OpenUrlPubMed
13. 13.↵
    1. Sochet AA,
    2. Havlicek EE,
    3. Faustino EVS,
    4. Goldenberg NA

    . Venous thromboembolism among children undergoing invasive mechanical ventilation: a multi-center, retrospective cohort study. Hosp Pediatr 2022;12(12):1099-1109.

    OpenUrlPubMed
14. 14.↵
    1. Branchford BR,
    2. Mourani P,
    3. Bajaj L,
    4. Manco-Johnson M,
    5. Wang M,
    6. Goldenberg NA

    . Risk factors for in-hospital venous thromboembolism in children: a case control study employing diagnostic validation. Haematologica 2012;97(4):509-515.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Havlicek EE,
    2. Goldman ZA,
    3. Faustino EVS,
    4. Ignjatovic V,
    5. Goldenberg NA,
    6. Sochet AA

    . Hospital-acquired venous thromboembolism during invasive ventilation in children: a single-center, retrospective cohort study. J Thromb Haemost 2023;21(11):3145-3152. [Epub ahead of print]

    OpenUrlPubMed
16. 16.↵
    1. Arlikar SJ,
    2. Atchison CM,
    3. Amankwah EK,
    4. Ayala IA,
    5. Barrett LA,
    6. Branchford BR,
    7. et al

    . Development of a new risk score for hospital-associated venous thromboembolism in critically ill children not undergoing cardiothoracic surgery. Thromb Res 2015;136(4):717-722.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Sochet AA,
    2. Jaffray J,
    3. Branchford BR,
    4. Havlicek EE,
    5. Mosha M,
    6. Amankwah EK,
    7. et al

    . Hospital-acquired venous thromboembolism and invasive ventilation: a report from the CHAT Consortium. Pediatr Crit Care Med 2023;25(2):e82-e90. [Epub ahead of print]

    OpenUrlPubMed
18. 18.↵
    1. Sochet AA,
    2. Morrison JM,
    3. Jaffray J,
    4. Godiwala N,
    5. Wilson HP,
    6. Thornburg CD,
    7. et al

    ; COVID-19 Anticoagulation in Children – Thromboprophylaxis (COVAC-TP) Trial Investigators. Enoxaparin thromboprophylaxis in children hospitalized for COVID-19: a phase 2 trial. Pediatrics 2022;150(1):e2022056726.

    OpenUrlPubMed
19. 19.↵
    1. Dain AS,
    2. Raffini L,
    3. Whitworth H

    . Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children. Curr Opin Pediatr 2022;34(3):261-267.

    OpenUrlPubMed
20. 20.↵
    1. O’Brien SH,
    2. Li D,
    3. Mitchell LG,
    4. Hess T,
    5. Zee P,
    6. Yee DL,
    7. et al

    . PREVAPIX-ALL: apixaban compared to standard of care for prevention of venous thrombosis in pediatric acute lymphoblastic leukemia (ALL)-rationale and design. Thromb Haemost 2019;119(5):844-853.

    OpenUrlPubMed
21. 21.↵
    1. Halton J,
    2. Brandão LR,
    3. Luciani M,
    4. Bomgaars L,
    5. Chalmers E,
    6. Mitchell LG,
    7. et al

    ; DIVERSITY Trial Investigators. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomized controlled, open-label, phase 2b/3, non-inferiority trial. Lancet Haematol 2021;8(1):e22-e33.

    OpenUrl
22. 22.↵
    1. Sloan EE,
    2. McCurdy D

    . The antiphospholipid syndrome in the pediatric population. Adv Pediatr 2022;69(1):107-121.

    OpenUrlPubMed
23. 23.↵
    1. Konopásek P,
    2. Piteková B,
    3. Krejčová V,
    4. Zieg J

    . Cerebral sinovenous thrombosis in children with nephrotic syndrome: systematic review and one new case. Front Pediatr 2023;11:1207871.

    OpenUrlPubMed
24. 24.↵
    1. Chima RS,
    2. Hanson SJ

    . Venous thromboembolism in critical illness and trauma: pediatric perspectives. Front Pediatr 2017;5(5):47.

    OpenUrlPubMed
25. 25.↵
    1. Petty JK

    . Venous thromboembolism prophylaxis in the pediatric trauma patient. Semin Pediatr Surg 2017;26(1):14-20.

    OpenUrlPubMed
26. 26.↵
    1. Haas T,
    2. Cushing MM

    . Hemostatic balance in severe trauma. Front Pediatr 2020;8:600501.

    OpenUrlPubMed
27. 27.↵
    1. Atchison CM,
    2. Amankwah E,
    3. Wilhelm J,
    4. Arlikar S,
    5. Branchford BR,
    6. Stock A,
    7. et al

    . Risk factors for hospital-associated venous thromboembolism in critically ill children following cardiothoracic surgery or therapeutic cardiac catheterization. Cardiol Young 2018;28(2):234-242.

    OpenUrlPubMed
28. 28.↵
    1. Faustino EVS,
    2. Shabanova V,
    3. Raffini LJ,
    4. Kandil SB,
    5. Li S,
    6. Pinto MG,
    7. et al

    ; on behalf of the CRETE Trial Investigators and the Pediatric Critical Care Blood Research Network (BloodNet) of the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI). Efficacy of early prophylaxis against catheter-associated thrombosis in critically ill children: a Bayesian phase 2b randomized clinical trial. Crit Care Med 2021;49(3):e235-e246.

    OpenUrlPubMed
29. 29.↵
    1. Faustino EVS,
    2. Raffini LJ,
    3. Hanson SJ,
    4. Cholette JM,
    5. Pinto MG,
    6. Li S,
    7. et al

    ; on behalf of the CRETE Trial Investigators and the Pediatric Critical Care Blood Research Network (BloodNet) of the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI.). Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children: a post hoc analysis of a Bayesian phase 2b randomized clinical trial. Crit Care Med 2021;49(4):e369-e380.

    OpenUrlPubMed
30. 30.↵
    1. Jaffray J,
    2. Branchford B,
    3. Goldenberg N,
    4. Malvar J,
    5. Croteau SE,
    6. Silvey M,
    7. et al

    . Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children’s Hospital-Acquired Thrombosis Consortium. J Pediatr 2021;228:252-259.e1.

    OpenUrlPubMed
31. 31.↵
    1. Ishola T,
    2. Kirk SE,
    3. Guffey D,
    4. Voigt K,
    5. Shah MD,
    6. Srivaths L

    . Risk factors and comorbidities in adolescent thromboembolism are different than those in younger children. Thromb Res 2016;141:178-182.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Biehl M,
    2. Kashiouris MG,
    3. Gajic O

    . Ventilator-induced lung injury: minimizing its impact in patients with or at risk for ARDS. Respir Care 2013;58(6):927-937.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Webb HH,
    2. Tierney DF

    . Experimental pulmonary edema due to intermittent positive-pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974;110(5):556-565.

    OpenUrlPubMedWeb of Science
34. 34.↵
    1. Dreyfuss D,
    2. Soler P,
    3. Basset G,
    4. Saumon G

    . High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137(5):1159-1164.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Matos MF,
    2. Lourenco DM,
    3. Orikaza CM,
    4. Bajerl JA,
    5. Noguti MA,
    6. Morelli VM

    . The role of IL-6, IL-8, and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT, and MCP-1 -2518AG in the risk of venous thromboembolism: a case control study. Thromb Res 2011;128(3):216-220.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Rossetti P,
    2. Goldoni M,
    3. Pengo V,
    4. Vescovini R,
    5. Mozzoni P,
    6. Tassoni MI,
    7. et al

    . MiRNA 126 as a new predictor biomarker in venous thromboembolism of persistent residual vein obstruction: a review of the literature plus a pilot study. Semin Thromb Hemost 2021;47(8):982-991.

    OpenUrlPubMed
37. 37.↵
    1. Yadav U,
    2. Mahemuti A,
    3. Hu X,
    4. Abudureheman K,
    5. Xia Y,
    6. Tang B,
    7. et al

    . Single nucleotide polymorphisms in interleukin-6 and their association with venous thromboembolism. Mol Med Rep 2015;11(6):4664-4670.

    OpenUrlPubMed
38. 38.↵
    1. Braga AJ,
    2. Young AE

    . Preventing venous thrombosis in critically ill children: what is the right approach? Paediatr Anaesth 2011;21(4):435-440.

    OpenUrlPubMed
39. 39.↵
    1. Raffini L,
    2. Trimarchi T,
    3. Beliveau J,
    4. Davis D

    . Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative. Pediatrics 2011;127(5):e1326-e1332.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Mahajerin A,
    2. Petty JK,
    3. Hanson SJ,
    4. Thompson AJ,
    5. O’Brien SH,
    6. Streck CJ,
    7. et al

    . Prophylaxis against venous thromboembolism in pediatric trauma: a practice management guideline from the Eastern Association for the Surgery of Trauma and the Pediatric Trauma Society. J Trauma Acute Care Surg 2017;82(3):627-636.

    OpenUrlPubMed
41. 41.↵
    1. Badawy SM,
    2. Rychlik K,
    3. Sharathkumar AA

    . Current practice of pharmacological thromboprophylaxis for prevention of venous thromboembolism in hospitalized children: a survey of pediatric hemostasis and thrombosis experts in North America. J Pediatr Hematol Oncol 2016;38(4):301-307.

    OpenUrlPubMed
42. 42.↵
    1. Amos LE,
    2. Silvey M,
    3. Hall M,
    4. Witmer CM,
    5. Carpenter SL

    . Primary thromboprophylaxis in hospitalized children: a multi-center retrospective analysis. Thromb Res 2019;176:1-7.

    OpenUrlPubMed
43. 43.↵
    1. Faustino EV,
    2. Hanson S,
    3. Spinella PC,
    4. Tucci M,
    5. O’Brien SH,
    6. Nunez AR,
    7. et al

    ; on behalf of the PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med 2014;42(5):1232-1240.

    OpenUrlCrossRefPubMed
44. 44.↵
    1. Stem J,
    2. Christensen A,
    3. Davis D,
    4. Raffini L

    . Safety of prophylactic anticoagulation at a pediatric hospital. J Pediatr Hematol Oncol 2013;35(7):e287-e291.

    OpenUrlCrossRefPubMed
45. 45.↵
    1. Onyeama SJ,
    2. Hanson SJ,
    3. Dasgupta M,
    4. Hoffmann RG,
    5. Faustino EV

    ; Prophylaxis against Thrombosis Practice Study Investigators. Factors associated with continuous low-dose heparin infusion for central venous catheter patency in critically ill children worldwide. Pediatr Crit Care Med 2016;17(8):e352-e361.

    OpenUrlPubMed
46. 46.↵
    1. Jamjoom AA,
    2. Chari A,
    3. Salijevska J,
    4. Meacher R,
    5. Brennan P,
    6. Statham P

    . A national survey of thromboprophylaxis in traumatic brain injury in the United Kingdom. Br J Neurosurg 2016;30(2):240-245.

    OpenUrlPubMed